Peregrine Asset Advisers Inc. Takes Position in SPDR S&P Biotech ETF $XBI

Peregrine Asset Advisers Inc. bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, HoldingsChannel.com reports. The fund bought 61,224 shares of the exchange traded fund’s stock, valued at approximately $7,465,000. SPDR S&P Biotech ETF comprises 2.1% of Peregrine Asset Advisers Inc.’s investment portfolio, making the stock its 9th largest position.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in XBI. AQR Capital Management LLC increased its stake in SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after acquiring an additional 2,167 shares during the period. Marshall Wace LLP increased its stake in SPDR S&P Biotech ETF by 102.3% in the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after acquiring an additional 179,029 shares during the period. The Manufacturers Life Insurance Company bought a new stake in SPDR S&P Biotech ETF in the second quarter valued at about $260,000. Ameriprise Financial Inc. increased its stake in SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after acquiring an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC increased its stake in SPDR S&P Biotech ETF by 3.7% in the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after acquiring an additional 193 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $130.42 on Monday. The stock has a market cap of $8.32 billion, a P/E ratio of 11.47 and a beta of 0.85. The company’s 50-day simple moving average is $127.98 and its 200 day simple moving average is $122.87. SPDR S&P Biotech ETF has a twelve month low of $75.68 and a twelve month high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.